Booster immunizations with DNA plasmids encoding HER-2/neu prevent spontaneous mammary cancer in HER-2/neu transgenic mice over life span
Abstract Cancer vaccines are less effective at old than at young age because of immunosenescence. Besides, in preliminary observations we showed that the immunization with HER-2/neu DNA plasmid in transgenic young mice (standard immunization, SI) delays but not abrogate spontaneous mammary tumours p...
Enregistré dans:
| Auteurs principaux: | Mauro Provinciali, Alessandra Barucca, Fiorenza Orlando, Elisa Pierpaoli |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Nature Portfolio
2017
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/30a26d3f0af04239af09033dd04f3b15 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Utility of Serum HER-2/ neu in Prediction of Tissue HER-2 /neu Status of Primary Breast Cancer
par: Maral Mokhtari, et autres
Publié: (2021) -
Cancer biomarker HER-2/neu in breast cancer in Indian women
par: Singhai R, et autres
Publié: (2011) -
Neu Perspectives, Therapies, and Challenges for Metastatic HER2-Positive Breast Cancer
par: Salkeni MA, et autres
Publié: (2021) -
Antiangiogenesis immunotherapy induces epitope spreading to Her-2/neu resulting in breast tumor immunoediting
par: Matthew M Seavey, et autres
Publié: (2009) -
Applicability and interpretation of HER2/Neu & PD-L1 stains in gastrointestinal tract tumours
par: Prasenjit Das, et autres
Publié: (2021)